Venous thromboembolism (VTE) prevention program implementation in a community oncology practice: author response to Yang et al

Venous thromboembolism (VTE) prevention program implementation in a community oncology practice: author response to Yang et al

Saved in:

Bibliographic Details
Main Authors:	Steven Ades, Chris Holmes
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	The Lancet Regional Health. Americas
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667193X24003077
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Arterial Thromboembolism in Patients With Advanced Lung Cancer: Secondary Analyses of the Rising‐VTE/NEJ037 Study
by: Naoki Furuya, et al.
Published: (2025-01-01)

SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP
by: Alessandro Laganà, et al.
Published: (2024-02-01)

Strategies for Diagnosis and Prevention of Venous Thromboembolism during Pregnancy
by: Shalini Jain Bagaria, et al.
Published: (2011-01-01)

Venous thromboembolic events: case history
by: T.V. Shelkovnikova, et al.
Published: (2019-11-01)

Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies
by: Nikola Vladic, et al.
Published: (2025-01-01)

Comment on: Multimorbidity, comorbidity, frailty, and venous thromboembolism
by: Maria I. Zervou, et al.
Published: (2025-02-01)

PERIOPERATIVE PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ROUTINE ONCOSURGERY
by: V. E. Khoronenko, et al.
Published: (2016-12-01)

Venous thromboembolism still leads on maternal death
by: Amelia Shard, et al.
Published: (2025-01-01)

Intermittent pneumatic compression for venous thromboembolism prevention: a systematic review on factors affecting adherence
by: Richard Greenall, et al.
Published: (2020-09-01)

Response to Comment on: Multimorbidity, comorbidity, frailty, and venous thromboembolism
by: Bengt Zöller, et al.
Published: (2025-02-01)

Current Status of New Anticoagulants in the Management of Venous Thromboembolism
by: Roberto C. Montoya, et al.
Published: (2012-01-01)

Anticoagulation in venous thromboembolism in Behçet’s syndrome: friend or foe?
by: Rosaria Talarico, et al.
Published: (2024-12-01)

Racial disparities in extended venous thromboembolism prophylaxis after hysterectomy.
by: Wenbo Wu, et al.
Published: (2025-01-01)

Biological Aging and Venous Thromboembolism: A Review of Telomeres and Beyond
by: Rafaela Vostatek, et al.
Published: (2024-12-01)

Causal relationship between educational attainment and the occurrence of venous thromboembolism
by: Sitong Guo, et al.
Published: (2025-02-01)

Survey of Perceptions and Practices among Canadian Gastroenterologists regarding the Prevention of Venous Thromboembolism for Hospitalized Inflammatory Bowel Disease Patients
by: Roshan Razik, et al.
Published: (2012-01-01)

Venous thromboembolism in bullous pemphigoid: current evidence and update on systematic review
by: Atheer G. Almutairi, et al.
Published: (2025-01-01)

Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism
by: Marte Svalastoga, et al.
Published: (2025-01-01)

Enhancing Venous Thromboembolism Risk Prediction through Novel Biomarkers and Inflammatory Indicators
by: Zainab Wahab Al-Maaroof
Published: (2024-12-01)

A nomogram predicting the risk of venous thromboembolism in patients following urologic surgeries
by: Mengchao Wei, et al.
Published: (2025-01-01)

RISK FACTORS FOR THE DEVELOPMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH UNCOMPLICATED ACUTE CALCULOUS CHOLECYSTITIS
by: Mariya Kavka
Published: (2023-10-01)

A new risk assessment model of venous thromboembolism by considering fuzzy population
by: Xin Wang, et al.
Published: (2024-12-01)

THE NATIONAL ONCOLOGICAL PROGRAM IMPLEMENTATION – EXPERIENCE IN THE VLADIMIR REGION (TO THE 70TH ANNIVERSARY OF THE REGIONAL CLINICAL ONCOLOGICAL DISPENSARY)
by: A. G. Zirin, et al.
Published: (2017-03-01)

Evaluation of Rivaroxaban Exposure via Anti-Xa Levels During VTE Prophylaxis in Hospitalized Patients
by: Kaitlin Blotske PharmD, et al.
Published: (2025-02-01)

Evaluation of Risk Factors of Venous Thromboembolism in Imam Sadiq Teaching Hospital at Babylon City
by: Intisar Mahdi Kadhim Almurshedi, et al.
Published: (2022-11-01)

Evaluating chemical venous thromboembolism prophylaxis in trauma patients at a single Australian center
by: Natalie Quarmby, et al.
Published: (2024-09-01)

Risk of Venous Thromboembolism in Patients Nursed at Home or in Long-Term Care Residential Facilities
by: Guido Arpaia, et al.
Published: (2011-01-01)

Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?
by: Yachar Dawudi, et al.
Published: (2025-01-01)

Multimorbidity is associated with risk of incident venous thromboembolism – A nationwide proof-of-concept study
by: Jonatan Ahrén, et al.
Published: (2025-03-01)

Circulating, Extracellular Vesicle-Associated Tissue Factor in Cancer Patients with and without Venous Thromboembolism
by: Valentina Lami, et al.
Published: (2025-01-01)

Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism
by: Daniella Veloria, et al.
Published: (2025-03-01)

Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia
by: Abdulaali R. Almutairi PhD, et al.
Published: (2025-02-01)

Risk factors for venous thromboembolism after hip arthroscopy: a systematic review and meta-analysis
by: Haoxuan Li, et al.
Published: (2025-02-01)

Frequency and treatment of venous thromboembolic events in patients with space-occupying brain infarction and decompressive craniectomy
by: Dominik Michalski, et al.

Efficacy and safety of rivaroxaban in preventing venous thromboembolism in postoperative patients with gynecological malignancies: protocol for a randomised controlled open-label trial (G-alfalfa trial)
by: Hong Zhou, et al.
Published: (2024-12-01)

Large Left Ventricular Thrombus in a Patient with Systemic and Venous Thromboembolism Secondary to Protein C and S Deficiency
by: Mohit Pahuja, et al.
Published: (2017-01-01)

Global Research Hotspots in Venous Thromboembolism Anticoagulation: A Knowledge-Map Analysis from 2012 to 2021
by: Jia Wang, et al.
Published: (2023-01-01)

Investigating the dual causative pathways linking immune cells and venous thromboembolism via Mendelian randomization analysis
by: Ning Qi, et al.
Published: (2025-01-01)

Incidence, Risk Factors, and Modified Risk Assessment Model of Venous Thromboembolism in Non‐Hodgkin Lymphoma Patients
by: Wen Li, et al.
Published: (2024-12-01)

17 The risk of venous thromboembolism after cystectomy and prostatectomy with or without a pelvic lymph-node dissection
by: O. Akre, et al.
Published: (2025-01-01)